Outlook Therapeutics Income Statement (2015-2025) | OTLK

1Y3Y5Y7Y10YAll
Download Data
Income Statement Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Revenue & cost
Revenue 0.49M1.29M0.49M0.99M0.99M0.49M0.49M0.30M0.30M0.30M2.90M0.77M0.77M0.77M0.77M1.07M0.64M0.58M5.85M-0.60M-0.70M-0.44M1.51M-0.09M
Cost of Revenue 0.44M0.92M0.03M
Gross Profit 1.07M-1.01M-1.24M
Operating items
Research & Development 10.15M9.68M13.20M12.73M4.14M12.02M3.87M13.23M4.12M4.16M2.30M0.40M5.16M5.80M7.15M6.07M5.94M4.34M7.46M5.85M4.38M8.49M4.41M7.13M5.98M3.63M
Selling, General & Administrative 4.34M2.66M4.67M4.67M-0.19M10.50M6.57M4.87M4.02M3.48M3.51M3.55M2.45M2.20M6.04M2.90M1.85M1.83M2.78M2.34M1.96M3.29M7.98M9.68M10.33M8.61M
Other Operating Expenses 2.35M0.56M0.05M8.31M0.42M0.10M-46.22M
Operating Expenses 14.50M12.34M17.87M17.41M3.95M22.52M10.45M18.10M8.14M7.64M5.81M3.95M7.60M7.99M13.19M11.32M8.35M6.23M18.55M8.18M6.76M11.88M12.39M16.81M-29.91M12.25M
Operating Income -14.00M-11.05M-17.37M-16.41M-2.95M-22.03M-9.95M-17.80M-7.84M-7.34M-2.91M-3.18M-6.83M-7.22M-12.41M-10.26M-7.71M-5.64M-12.69M-8.18M-6.76M-11.88M-12.39M-15.75M-17.31M-13.48M
EBIT -14.00M-11.05M-17.37M-16.41M-2.95M-22.03M-9.95M-17.80M-7.84M-7.34M-2.91M-3.18M-6.83M-7.22M-12.41M-10.26M-7.71M-5.64M-12.69M-8.18M-6.76M-11.88M-12.39M-15.75M-17.31M-13.48M
Non-operating items
Other Non Operating Income -1.25M-0.18M-0.42M-8.06M6.16M
Net income details
EBT -14.71M-11.60M-18.05M-16.81M-3.49M-22.33M-10.57M-19.09M-8.05M-5.33M-5.88M-5.07M-7.54M-8.43M-12.70M-9.74M-10.24M-5.22M-12.73M-8.78M-5.70M-6.29M-46.35M-20.15M-14.85M-13.48M
Tax Provisions -0.73M0.12M0.01M0.05M0.05M500.000.00M0.50M-3.15M-0.50M-0.78M-2.63M-3.27M0.00M-1.55M
Profit After Tax -13.98M-11.72M-18.06M-16.86M-3.54M-22.33M-10.57M-19.10M-8.05M-5.33M-6.37M-1.92M-7.54M-8.43M-12.20M-9.74M-10.24M-4.44M-10.10M-16.60M-5.70M-3.01M-46.36M-20.15M-13.29M-13.48M
Equity Income -0.04M-0.03M-0.04M-0.04M
Income from Non-Controlling Interests -0.38M-0.90M
Income from Continuing Operations -13.98M-11.72M-18.06M-16.86M-3.54M-22.33M-10.57M-19.10M-8.05M-5.33M-6.37M-1.92M-7.54M-8.43M-12.20M-9.74M-10.24M-4.44M-10.10M-8.78M-5.70M-3.01M-46.36M-20.15M-13.29M-13.48M
Consolidated Net Income -13.98M-11.72M-18.06M-16.86M-3.54M-22.33M-10.57M-19.10M-8.05M-5.33M-6.37M-1.92M-7.54M-8.43M-12.20M-9.74M-10.24M-4.44M-10.10M-8.78M-5.70M-3.01M-46.36M-20.15M-13.29M-13.48M
Income towards Parent Company -13.98M-11.72M-18.06M-16.86M-3.54M-22.33M-10.57M-19.10M-8.05M-5.33M-6.37M-1.92M-7.54M-8.43M-12.20M-9.74M-10.24M-4.44M-10.10M-8.78M-5.70M-3.01M-46.36M-20.15M-13.29M-13.48M
Preferred Dividend Payments 1.03M1.09M1.11M0.94M1.03M0.49M0.45M0.64M0.65M0.16M0.15M0.15M0.16M0.16M0.17M
Net Income towards Common Stockholders -15.08M-12.43M-18.27M-17.80M-4.57M-30.19M-10.57M-19.10M-8.05M-5.33M-7.55M-17.73M-8.56M-9.08M-12.65M-9.89M-11.29M-4.60M-10.26M-18.48M-17.46M-3.01M-46.36M-20.15M-13.29M-23.06M
Additional items
EPS (Basic) -1.61-1.30-1.87-1.36-0.32-1.60-0.61-0.82-0.34-0.22-0.31-0.71-2.66-2.100.22-1.00-0.98-0.20-0.24-0.62-0.36-0.03-1.50-0.55-0.38-0.38
EPS (Weighted Average and Diluted) -0.32-1.60-0.61-0.38-0.22-0.31-0.33-0.26-0.32-0.03-1.50-0.55-0.38-0.38
Shares Outstanding (Weighted Average) 9.38M9.59M9.75M13.06M14.16M18.82M17.21M23.20M23.72M24.44M24.02M25.00M3.22M4.32M4.93M9.84M11.53M23.01M18.19M29.90M47.90M90.76M24.23M34.80M60.21M
Shares Outstanding (Diluted Average) 14.16M18.82M17.21M23.80M24.44M24.04M25.73M34.54M39.46M90.76M24.23M34.80M60.21M
EBITDA -14.00M-11.05M-17.37M-16.41M-2.95M-22.03M-9.95M-17.80M-7.84M-7.34M-2.91M-3.18M-6.83M-7.22M-12.41M-10.26M-7.71M-5.64M-12.69M-8.18M-6.76M-11.88M-12.39M-15.75M-17.31M-13.48M
Interest Expenses 0.71M0.55M0.68M0.40M0.54M0.30M0.62M0.49M1.24M1.75M2.15M0.72M0.92M1.15M1.11M1.12M1.05M1.08M0.21M0.60M0.70M0.44M
Tax Rate 4.94%-1.03%-0.05%-0.31%-1.45%0.00%-0.02%-8.47%62.13%3.92%14.90%20.69%52.04%-0.01%10.47%